129 related articles for article (PubMed ID: 38499117)
1. Association between prenatal antipsychotic exposure and the risk of attention-deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis.
Wang Z; Yuen AS; Wong KH; Chan AY; Coghill D; Simonoff E; Lau WC; Wong IC; Park S; Man KK
Neurosci Biobehav Rev; 2024 May; 160():105635. PubMed ID: 38499117
[TBL] [Abstract][Full Text] [Related]
2. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study.
Hálfdánarson Ó; Cohen JM; Karlstad Ø; Cesta CE; Bjørk MH; Håberg SE; Einarsdóttir K; Furu K; Gissler M; Hjellvik V; Kieler H; Leinonen MK; Nørgaard M; Öztürk Essen B; Ulrichsen SP; Reutfors J; Zoega H
Evid Based Ment Health; 2022 May; 25(2):54-62. PubMed ID: 34810174
[TBL] [Abstract][Full Text] [Related]
4. Gestational and Neurodevelopmental Outcomes Associated With Antipsychotic Drug Exposure During Pregnancy.
Andrade C
J Clin Psychiatry; 2021 Oct; 82(5):. PubMed ID: 34644464
[TBL] [Abstract][Full Text] [Related]
5. Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, and Other Neurodevelopmental Outcomes Associated With Antipsychotic Drug Exposure During Pregnancy.
Andrade C
J Clin Psychiatry; 2022 May; 83(3):. PubMed ID: 35649168
[TBL] [Abstract][Full Text] [Related]
6. Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study.
Chan AYL; Gao L; Howard LM; Simonoff E; Coghill D; Ip P; Lau WCY; Taxis K; Wong ICK; Man KKC
Psychother Psychosom; 2023; 92(2):113-123. PubMed ID: 36907183
[TBL] [Abstract][Full Text] [Related]
7. Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.
Tadesse AW; Dachew BA; Ayano G; Betts K; Alati R
J Psychiatr Res; 2024 Mar; 171():142-151. PubMed ID: 38281464
[TBL] [Abstract][Full Text] [Related]
8. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
[TBL] [Abstract][Full Text] [Related]
9. Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders.
Chen VC; Wu SI; Lin CF; Lu ML; Chen YL; Stewart R
JAMA Netw Open; 2022 Nov; 5(11):e2243282. PubMed ID: 36413366
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
Morales DR; Slattery J; Evans S; Kurz X
BMC Med; 2018 Jan; 16(1):6. PubMed ID: 29332605
[TBL] [Abstract][Full Text] [Related]
11. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
12. Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study.
Njotto LL; Simin J; Fornes R; Odsbu I; Mussche I; Callens S; Engstrand L; Bruyndonckx R; Brusselaers N
Drug Saf; 2023 May; 46(5):467-478. PubMed ID: 37087706
[TBL] [Abstract][Full Text] [Related]
13. Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study.
Ge GM; Cheung ECL; Man KKC; Ip P; Leung WC; Li GHY; Kung AWC; Cheung CL; Wong ICK
BMC Med; 2022 Nov; 20(1):390. PubMed ID: 36344981
[TBL] [Abstract][Full Text] [Related]
14. Maternal polycystic ovary syndrome and the potential risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in the offspring: a systematic review and meta-analysis.
Abu-Zaid A; Bhagavathula AS; Rahmani J; Alyoubi RA; Alomar O; Baradwan S; Alkhamis WH; Khalifa M; Alshahrani MS; Khadawardi K; Salem H; A Al-Badawi I
Eur J Contracept Reprod Health Care; 2022 Jun; 27(3):253-260. PubMed ID: 35191798
[TBL] [Abstract][Full Text] [Related]
15. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study.
Andersen SL; Laurberg P; Wu CS; Olsen J
BJOG; 2014 Oct; 121(11):1365-74. PubMed ID: 24605987
[TBL] [Abstract][Full Text] [Related]
16. Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.
Kosidou K; Dalman C; Widman L; Arver S; Lee BK; Magnusson C; Gardner RM
Biol Psychiatry; 2017 Nov; 82(9):651-659. PubMed ID: 27889187
[TBL] [Abstract][Full Text] [Related]
17. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts.
Alemany S; Avella-García C; Liew Z; García-Esteban R; Inoue K; Cadman T; López-Vicente M; González L; Riaño Galán I; Andiarena A; Casas M; Margetaki K; Strandberg-Larsen K; Lawlor DA; El Marroun H; Tiemeier H; Iñiguez C; Tardón A; Santa-Marina L; Júlvez J; Porta D; Chatzi L; Sunyer J
Eur J Epidemiol; 2021 Oct; 36(10):993-1004. PubMed ID: 34046850
[TBL] [Abstract][Full Text] [Related]
18. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
19. Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.
Sujan AC; Öberg AS; Quinn PD; D'Onofrio BM
J Child Psychol Psychiatry; 2019 Apr; 60(4):356-376. PubMed ID: 30515808
[TBL] [Abstract][Full Text] [Related]
20. [Pre- and perinatal risk factors in autism spectrum disorder and attention deficit/hyperactivity disorder].
Schmitz JC; Cholemkery H; Medda J; Freitag CM
Z Kinder Jugendpsychiatr Psychother; 2017; 45(3):209-217. PubMed ID: 28128013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
